Formation of Hycult Biotech Inc.

Wednesday - December 1, 2010

Hycult Biotech b.v. Announces Formation of Hycult Biotech Inc. to Serve the Innate Immune Market Segment in the Americas.

Unique Products Focus on Immunology and Cell Biology Applications

Uden, The Netherlands, December 1, 2010 – Hycult Biotechnology bv  (Hycult Biotech) announced today the formation of Hycult Biotech Inc. a wholly owned subsidiary located in Plymouth Meeting, PA.  The Company specializes in the development, manufacture and commercialization of antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields.  
“The formation of a U.S. based subsidiary is a key milestone for our company and our customers in the Americas.  Our intention is to enable our end users research by facilitating access our products and technical support in a cost effective and productive manner.” said Rik van Heijningen, Managing Director of Hycult Biotech. 
Mr. van Heijningen continued, “Our mission is to advance research in innate immunity related diseases, for the benefit of individuals and to improve their quality of life. We recognize the significance of the scientific accomplishments in The Americas and intend to translate our move into a true benefit for the immunologist and cell biologist accelerating research in these important fields.”
Hycult Biotech Inc. is an operating entity as of today, and will be providing customer service, technical sales, technical support, and product logistics to Hycult Biotech customers in North and South America from Dec 2nd, 2010.

About Hycult Biotech
Hycult Biotech is a leader in the fields of immunology and cell biology, we develop, produce and market antibodies, antibody based products and more specifically immunoassays for innate immunity and directly related fields, with an emphasis on complement, neutrophil proteins, TLR, scavenger receptors and acute phase proteins. Furthermore, we have a strong interest in progressing research in the area of inflammation and cell damage caused by pathogens or oxidation factors.

Media Contact
Sandra van der Horst
Tel:          +31 (0)413 251335
Fax:         +31 (0)413 248353
www.hycultbiotech.com

Other news
Nate: Hycult Biotech's Mascot Read this article » Shock Conference, June 9th - 13th, Miami Beach, FL Read this article » New Antibody Sampler Packs US Read this article » New: Flow Cytometry Brochure! Read this article » NEW: Human Properdin ELISA Read this article » Low Endotoxin Antibodies for Functional Studies Read this article » BSA-free Antibodies for Immuno Assays Read this article » Now available: 1-plate assays! Read this article » Special Formulations and Service Read this article » 2012 US Hycult Biotech Catalog Read this article » Discounts for Publication References Read this article » Government Accounts Read this article » American Assoc. of Immunology Meeting Read this article » Human Properdin ELISA and mAbs Read this article » Immuno Assay mAbs Read this article » Single-Plate ELISAs Read this article » Functional Study, Low Endotoxin mAbs Read this article » PTX3, a biomarker for vascular inflammation Read this article » Upgrade I-FABP ELISA (Cat.#HK406) Read this article » Visit us at MEDICA Read this article » New R-PE monoclonals available Read this article » Hycult Biotech Inc Bronze Sponsor SLB Read this article » NEW product: Human CRP ELISA Read this article » Hycult Biotech Gold Sponsor EMCHD 2011 Read this article » Discount Human LBP ELISA and Human sCD14 ELISA Read this article » Variant-specific quantification of factor H Read this article » Increased Exposure to Bacterial Antigen RpL7/L12 Read this article » IgG glycan hydrolysis Read this article » Differential role of the lectin pathway Read this article » C1q deficiency linked to autoimmune disorders Read this article » New Complement Proteins available Read this article » New Human Complement Factor D ELISA Read this article » Unique ELISA to elucidate the role of human MASP-3 Read this article » Mast cells, basophils and eosinophils Read this article » Unique antibodies for functional studies Read this article » C1q product release Read this article » Human SAA ELISA Read this article »